RxDoctor Payments Data

Mark Promersberger, MD

Ophthalmology · Martinsburg, WVNPI 1760415228

Payments from drug & device makers

What this record shows

This record is dominated by other: $2,120 of the $2,590 with a category attached, or 81.9%. Carl Zeiss Meditec USA, Inc. accounts for 81.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,633 and has fallen 91.6% since, to $138 in 2025.

$2,590in general payments, 2019–2025

Across 20 payments — averaging $129.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$2K
  • Alcon$169
  • Amgen$95
  • Johnson & Johnson Surgical Vision, Inc.$68
  • Carl Zeiss Meditec AG$39
  • NEW World Medical,inc.$38
  • plus $62 from 3 others

What the payments were for

  • Food & beverage$43117%
  • Gifts$391%
  • Other$2,12082%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,590 in reported general payments places this provider in the 70th percentile of 85 ophthalmology providers in West Virginia.

See all ophthalmology providers in West Virginia

Medicare billing

Part B allowed, 2024
$349,912
Medicare patients
1,697
Services billed
2,930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine70$77,316
LumiganBimatoprost78$27,698
Cyclosporine28$18,780
XiidraLifitegrast12$14,023
CombiganBrimonidine Tartrate/Timolol38$9,127
Prednisolone Acetate216$6,432
RocklatanNetarsudil Mesylat/Latanoprost12$4,149
TobradexTobramycin/Dexamethasone15$3,862
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol23$3,721
Latanoprost402$3,652
Travoprost21$3,509
Tobramycin-DexamethasoneTobramycin/Dexamethasone68$2,772
Alphagan PBrimonidine Tartrate13$2,381
Ketorolac Tromethamine44$1,955
Timolol Maleate42$1,285

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Martinsburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →